Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Radiation after lumpectomy may be unnecessary for many older women

02.09.2004


Tamoxifen alone may adequately control breast cancer, avoiding side effects



Older women treated with tamoxifen after removal of early-stage breast cancer by lumpectomy may safely be able to avoid radiation therapy and its unpleasant side effects. In the Sept. 2 New England Journal of Medicine, investigators from several major cancer research groups report that adding radiation to post-surgical tamoxifen treatment of women age 70 or older does not improve survival, has minimal impact on the risk of local tumor recurrence and does not prevent the need for eventual mastectomy. “If a patient does not need to have radiation therapy, her quality of life can improve significantly,” says Kevin Hughes, MD, of the Massachusetts General Hospital (MGH) Cancer Center, who led the study. “By showing that radiation therapy has very little impact on outcome for these patients, we can help each woman and her physician decide on the right treatment.”

Many breast cancers depend on the hormone estrogen to grow. So tamoxifen, which blocks the interaction between estrogen and its receptor protein, is used to treatment tumors that have that protein on the surface of their cells. Most older breast cancer patients have receptor-positive tumors and receive tamoxifen, a medication that has few side effects.


Radiation has been a standard post-surgical treatment for women having lumpectomies, but the therapy can be both inconvenient and unpleasant, with side effects such as pain, swelling, and skin discoloration. Several studies have shown that, although radiation reduces tumor recurrence, it does not improve overall survival. Because breast cancer is less likely to recur in older women, the research team investigated whether such patients might do well if they receive tamoxifen alone after surgery.

Over a five-year period, more than 600 patients at almost 30 centers across the U.S. enrolled in the study. All the participants were age 70 or older, with early-stage (2 cm or less), receptor-positive tumors that had been removed in lumpectomy procedures. They were randomly assigned to receive either tamoxifen alone or tamoxifen plus radiation as postsurgical treatment.

At the end of the study period, the only significant difference between the groups was in the risk that the tumor would recur at or near its original site. Both groups had very low rates of recurrence; but while those in the tamoxifen-only group had a 4 percent risk, those who also received radiation had an only 1 percent risk. There were no significant differences in terms of distant metastasis, the need for mastectomy after recurrence or overall survival. Both groups had exactly the same number of breast cancer deaths – three in each group, a rate that reflects the less aggressive nature of breast cancer in this age group. As expected, those receiving radiation reported more pain, swelling, stiffness and other side effects than did the tamoxifen-only participants.

“The local recurrence risk in both groups was extremely low, and women who have not had radiation have the option of another lumpectomy if they do have recurrence in the same breast. Once a patient has had radiation, however, she must have a mastectomy if her tumor recurs,” says Hughes, an assistant professor of Surgery at Harvard Medical School. “In the long run, each woman and her physician should choose a treatment plan by weighing the slightly increased local recurrence risk against the virtually certain costs of radiation – the patient’s time, adverse effects, and financial costs.”

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu

More articles from Materials Sciences:

nachricht Decoding cement's shape promises greener concrete
08.12.2016 | Rice University

nachricht Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D
08.12.2016 | DOE/Brookhaven National Laboratory

All articles from Materials Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>